Literature DB >> 30286384

Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.

Allan Wang1, Keyana Foster2, Patrick Skeba2, Kasidet Hiranniramol2, Christopher J Earley3, Richard P Allen4.   

Abstract

Entities:  

Keywords:  Dopamine; Insomnia; Periodic leg movements; Restless leg syndrome; Withdrawal

Mesh：

Substances：

Year:  2018        PMID： 30286384      PMCID： PMC6289284          DOI： 10.1016/j.sleep.2018.08.005

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  17 in total

1.  Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).

Authors:  D Tzonova; O Larrosa; E Calvo; J J Granizo; A-M Williams; Y de la Llave; D García-Borreguero
Journal:  Sleep Med       Date:  2012-01-26       Impact factor: 3.492

2.  The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG).

Authors:  Marco Zucconi; Raffaele Ferri; Richard Allen; Paul Christian Baier; Oliviero Bruni; Sudhansu Chokroverty; Luigi Ferini-Strambi; Stephany Fulda; Diego Garcia-Borreguero; Wayne A Hening; Max Hirshkowitz; Birgit Högl; Magdolna Hornyak; Martin King; Pasquale Montagna; Liborio Parrino; Giuseppe Plazzi; Mario G Terzano
Journal:  Sleep Med       Date:  2006-02-03       Impact factor: 3.492

3.  Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.

Authors:  Markku Partinen; Kari Hirvonen; Leni Jama; Anniina Alakuijala; Christer Hublin; Ilkka Tamminen; Juergen Koester; Juergen Reess
Journal:  Sleep Med       Date:  2006-07-03       Impact factor: 3.492

4.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Authors:  Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee
Journal:  Sleep Med       Date:  2014-05-17       Impact factor: 3.492

5.  Augmentation of the restless legs syndrome with carbidopa/levodopa.

Authors:  R P Allen; C J Earley
Journal:  Sleep       Date:  1996-04       Impact factor: 5.849

6.  The PAM-RL ambulatory device for detection of periodic leg movements: a validation study.

Authors:  Emilia Sforza; Mathis Johannes; Bassetti Claudio
Journal:  Sleep Med       Date:  2005-04-01       Impact factor: 3.492

7.  Correlation between rating scales and sleep laboratory measurements in restless legs syndrome.

Authors:  Diego Garcia-Borreguero; Oscar Larrosa; Yolanda de la Llave; Juan José Granizo; Richard Allen
Journal:  Sleep Med       Date:  2004-11       Impact factor: 3.492

Review 8.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

9.  Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.

Authors:  Diego Garcia-Borreguero; Michael H Silber; John W Winkelman; Birgit Högl; Jacquelyn Bainbridge; Mark Buchfuhrer; Georgios Hadjigeorgiou; Yuichi Inoue; Mauro Manconi; Wolfgang Oertel; William Ondo; Juliane Winkelmann; Richard P Allen
Journal:  Sleep Med       Date:  2016-02-23       Impact factor: 3.492

10.  Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics.

Authors:  Richard P Allen; Paul Stillman; Andrew J Myers
Journal:  Sleep Med       Date:  2009-05-22       Impact factor: 3.492
View more
  1 in total

1.  Moderate to severe but not mild RLS is associated with greater sleep-related sympathetic autonomic activation than healthy adults without RLS.

Authors:  Byungjoo Jin; Allan Wang; Christopher Earley; Richard Allen
Journal:  Sleep Med       Date:  2019-10-05       Impact factor: 3.492
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.